Donor Type Does Not Impact Late Graft Failure Following Reduced Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Based Graft-Versus-Host Disease Prophylaxis.
Hickey CL, Zhang MJ, Allbee-Johnson M, Romee R, Majhail NS, Malki MMA, Antin JH, Benjamin CL, Bredeson C, Chhabra S, Grunwald MR, Inamoto Y, Kanakry CG, Milano F, Soiffer RJ, Solomon SR, Spellman SR, Brunstein CG, Cutler C.
Hickey CL, et al. Among authors: zhang mj.
Transplant Cell Ther. 2025 Jan 2:S2666-6367(24)00840-6. doi: 10.1016/j.jtct.2024.12.021. Online ahead of print.
Transplant Cell Ther. 2025.
PMID: 39755256